According to X4 Pharmaceuticals 's latest financial reports the company's current earnings are A$1.12 Million. In 2023 the company made an earning of -A$0.16 Billion a decrease over its 2022 earnings that were of -A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -A$24.73 Million | -84.34% |
2023 | -A$0.16 Billion | 7.73% |
2022 | -A$0.15 Billion | 5.82% |
2021 | -A$0.14 Billion | 43.07% |
2020 | -A$96.79 Million | 17.38% |
2019 | -A$82.46 Million | 22.75% |
2018 | -A$67.18 Million | 26.99% |
2017 | -A$52.9 Million |